Literature DB >> 2110360

Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors.

Q Yue1, C von Bahr, I Odar-Cederlöf, J Säwe.   

Abstract

Glucuronidation of codeine was detected and compared with that of morphine in microsomes from human livers and kidneys. Vmax values for codeine-6-glucuronide (C6G) were 0.54 +/- 0.24 and 0.74 +/- 0.35 nmol/mg/min. in the livers and 0.10 and 0.13 nmol/mg/min. in the kidney, respectively, when codeine and UDP-glucuronic acid (UDPGA) were incubated with microsomal preparation. The corresponding Km values were 2.21 +/- 0.68 and 1.41 +/- 0.36 mM in the livers and 6.69 and 4.12 mM in the kidney. The average codeine glucuronyltransferase (GT) activity was 14-fold lower in the six kidneys than in the 11 livers. Higher GT activities were observed in liver microsomes from patients who had been exposed to enzyme inducers. Rates of glucuronide formation from morphine correlated significantly with those from codeine in both human liver and kidney microsomes. Morphine, amitriptyline, diazepam, probenecid and chloramphenicol inhibited codeine glucuronidation with Ki values of 3.6, 0.13, 0.18, 1.7 and 0.27 mM, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110360     DOI: 10.1111/j.1600-0773.1990.tb00737.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  9 in total

1.  Lack of effect of paracetamol on the pharmacokinetics and metabolism of codeine in man.

Authors:  A Somogyi; F Bochner; Z R Chen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction.

Authors:  M Strolin Benedetti; R Whomsley; E Baltes; F Tonner
Journal:  Eur J Clin Pharmacol       Date:  2005-11-24       Impact factor: 2.953

3.  S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.

Authors:  Kushari Bowalgaha; David J Elliot; Peter I Mackenzie; Kathleen M Knights; Stellan Swedmark; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

4.  Extrahepatic metabolism of zidovudine.

Authors:  J L Howe; D J Back; J Colbert
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

5.  Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.

Authors:  Z R Chen; A A Somogyi; G Reynolds; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

6.  The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.

Authors:  R Pöyhiä; T Seppälä; K T Olkkola; E Kalso
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

7.  A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.

Authors:  Q Y Yue; J O Svensson; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

Review 8.  Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).

Authors:  Kathleen M Knights; Andrew Rowland; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

9.  Genistein Improves Liver Damage in Male Mice Exposed to Morphine.

Authors:  Mohammad Reza Salahshoor; Shiva Roshankhah; Payman Hosseni; Cyrus Jalili
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.